Archives

The Horizon Europe programme has funded the TBVAC-HORIZON project to improve the understanding of lung immunity to tuberculosis infection and to establish a diversified innovative TB vaccine [...]

The four EDCTP-funded late-stage TB vaccine development projects: POR TB Consortium, priMe and MTBVAC-Newborns Phase 2a and MTBVACN3, meet on a regular basis to exchange knowledge and [...]

TB remains one of the leading causes of death from an infectious agent. In 2021 – 10.6 million people fell sick with TB; 1.6 million people died. New vaccines that are effective against all forms [...]

The Institut Pasteur IN-PERSON TB course will be held in Paris on the Pasteur campus June 5 – 16, 2023. The  flyer describes the course program, and more information is available on the website: [...]

In Silico Trials methodologies will play a growing and fundamental role in the development and de-risking of new medical devices in the future. While the regulatory pathway for Digital Patient [...]

The WHO Global TB Report 2022 provides a comprehensive overview of the status of the TB epidemic and shows the progress in the response at different levels in the context of global commitments, [...]

The University of Cape Town (UCT) has two Postdoc vacancies: Postdoctoral Fellowship in Tuberculosis Immunology Postdoctoral Fellowship in Single Cell Clinical Immunology

From 10-12 May 2022, the Kick-off Meeting (KoM) of the MTBVAC phase III clinical trial EDCTP co-funded project was held in Baiona, Spain. With the only licensed TB vaccine, Bacillus [...]

Vaccine Development Services: Deadline May 31st, 2022 Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not [...]

To enhance the coordination and collaboration between the EDCTP-funded TB vaccine research projects, the four TB vaccine research projects meet annually to exchange knowledge and experiences on [...]